HLA分型市场－全球产业规模、份额、趋势、机会及预测，依技术、应用、产品、最终用户、地区及竞争格局划分，2020-2030年预测

2024年全球HLA分型市场规模为19.2亿美元，预计2030年将以6.50%的复合年增长率成长至28亿美元。人类白血球抗原（HLA）分型是指识别特定的HLA等位基因或等位基因群，以确定移植手术中捐赠者和受体之间的相容性，并评估疾病易感性。该市场的成长主要得益于全球对器官和造血干细胞移植需求的不断增长，以及分子诊断技术的持续进步，这些进步提高了HLA分析的精确度和效率。

主要市场驱动因素

器官和干细胞移植需求的不断增长显着推动了全球人类白血球抗原（HLA）分型市场的发展。随着需要进行挽救生命的移植手术的患者人数不断增加，精准的HLA配对对于预防移植排斥反应和改善患者预后至关重要。

主要市场挑战

市场发展面临的一大挑战在于，采用先进的高分辨率人类白血球抗原（HLA）分型技术并维护其运作所需的专业基础设施需要大量的资本投入。这笔巨额资金直接阻碍了全球HLA分型市场的扩张，为许多实验室设置了相当大的准入和升级障碍。

主要市场趋势

实验室自动化和高通量系统的广泛应用显着提升了实验室的运作效率。这一趋势透过简化复杂的工作流程和减少人工干预，满足了人们对快速、精准HLA分型日益增长的需求。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球HLA分型市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依技术分类（分子检测、基于序列的分子检测、非分子检测）
  • 按应用领域（诊断、研究）
  • 依产品分类（仪器、试剂及耗材、软体及服务）
  • 按最终用户（商业服务提供者、医院和移植中心、研究实验室和学术机构）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美HLA分型市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲HLA分型市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区HLA分型市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲HLA分型市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲HLA分型市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球HLA分型市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Qiagen LLC
• Omixon Inc.
• GenDx Products Inc.
• Illumina Inc.
• TBG Diagnostics Limited
• Becton, Dickinson and Company
• Takara Bio USA, Inc.
• F. Hoffman-La Roche Limited

第十六章：策略建议

第17章调查会社について・免责事项

The Global HLA Typing Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.80 Billion by 2030. Human Leukocyte Antigen (HLA) typing constitutes the process of identifying specific HLA alleles or groups of alleles to determine compatibility between donors and recipients in transplantation procedures and for assessing disease predisposition. The market's expansion is primarily supported by the increasing global demand for organ and hematopoietic stem cell transplantation, coupled with continuous advancements in molecular diagnostic techniques that enhance the precision and efficiency of HLA analysis.

Key Market Drivers

The increasing demand for organ and stem cell transplantation significantly drives the global Human Leukocyte Antigen typing market. As the number of patients requiring life-saving transplants grows, the critical need for precise HLA matching intensifies to prevent graft rejection and improve patient outcomes. This necessitates extensive HLA typing services for both recipients and an expanding donor pool.

Key Market Challenges

A substantial challenge for market development lies in the significant capital investment required for adopting advanced, high-resolution Human Leukocyte Antigen (HLA) typing technologies and maintaining the specialized infrastructure essential for their operation. This substantial financial outlay directly hampers the expansion of the global HLA typing market by creating considerable barriers to entry and upgrade for many laboratories. Establishing and equipping facilities with next-generation sequencing platforms and the necessary bioinformatics capabilities demands considerable upfront capital, which smaller institutions or those in regions with limited healthcare budgets often cannot afford.

Key Market Trends

The widespread adoption of laboratory automation and high-throughput systems represents a significant shift in operational efficiency. This trend addresses the increasing demand for rapid and precise HLA typing by streamlining complex workflows and reducing manual intervention. Automation enables laboratories to process a larger volume of samples with improved consistency, which is crucial for managing extensive donor registries and urgent transplant cases.

Key Market Players

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Qiagen LLC
• Omixon Inc.
• GenDx Products Inc.
• Illumina Inc.
• TBG Diagnostics Limited
• Becton, Dickinson and Company
• Takara Bio USA, Inc.
• F. Hoffman-La Roche Limited

Report Scope:

In this report, the Global HLA Typing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

HLA Typing Market, By Technique:

• Molecular Assay
• Sequenced-based Molecular Assay
• Non-Molecular Assay

HLA Typing Market, By Application:

• Diagnosis
• Research

HLA Typing Market, By Product:

• Instruments
• Reagents & Consumables
• Software & Services

HLA Typing Market, By End User:

• Commercial Service Providers
• Hospitals and Transplant Centers
• Research Labs & Academic Institutes

HLA Typing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global HLA Typing Market.

Available Customizations:

Global HLA Typing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global HLA Typing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Molecular Assay, Sequenced-based Molecular Assay, Non-Molecular Assay)
  • 5.2.2. By Application (Diagnosis, Research)
  • 5.2.3. By Product (Instruments, Reagents & Consumables, Software & Services)
  • 5.2.4. By End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Labs & Academic Institutes)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America HLA Typing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Application
  • 6.2.3. By Product
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States HLA Typing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada HLA Typing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico HLA Typing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End User

7. Europe HLA Typing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Application
  • 7.2.3. By Product
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany HLA Typing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End User
  • 7.3.2. France HLA Typing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom HLA Typing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy HLA Typing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain HLA Typing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End User

8. Asia Pacific HLA Typing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Application
  • 8.2.3. By Product
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China HLA Typing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End User
  • 8.3.2. India HLA Typing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan HLA Typing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea HLA Typing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia HLA Typing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End User

9. Middle East & Africa HLA Typing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Application
  • 9.2.3. By Product
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia HLA Typing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE HLA Typing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa HLA Typing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End User

10. South America HLA Typing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Application
  • 10.2.3. By Product
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil HLA Typing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia HLA Typing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina HLA Typing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global HLA Typing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories Inc.
• 15.3. Qiagen LLC
• 15.4. Omixon Inc.
• 15.5. GenDx Products Inc.
• 15.6. Illumina Inc.
• 15.7. TBG Diagnostics Limited
• 15.8. Becton, Dickinson and Company
• 15.9. Takara Bio USA, Inc.
• 15.10. F. Hoffman-La Roche Limited

16. Strategic Recommendations

17. About Us & Disclaimer